Literature DB >> 2987355

HLA-DR4-associated haplotypes are genotypically diverse within HLA.

S L Holbeck, S J Kim, J Silver, J A Hansen, G T Nepom.   

Abstract

Biochemical diversity among products of class II HLA genes has been observed in individuals who appear to be HLA-D and DR-identical by cellular and serologic typing. We used techniques of restriction enzyme fragment analysis by Southern blotting to analyze this diversity at the level of cellular DNA. A panel of 17 HLA-DR4 homozygous cell lines (HCL) were investigated by using cDNA probes homologous to DQ beta, DQ alpha, and DR beta genes. Each probe was hybridized to cellular DNA digested with a series of different restriction endonucleases. Polymorphisms were observed with the use of the enzymes Pst I, Hind III, and Bam HI: Hybridization of cellular DNA digested with Hind III and Pst I with the DQ beta probe revealed specific polymorphisms, as did hybridization of the Pst I digest with the DQ alpha cDNA probe and the Bam HI digest with the DR beta probe. The observed differences fall into two categories: first, considerable diversity was seen between HLA-DR4 HCL that represent different HLA-D-defined haplotypes; second, diversity was also observed among HCL of the same DR4-associated HLA-D cluster. In contrast to the DQ cDNA probes, hybridization with the DR beta probe revealed relatively limited polymorphism by using a panel of different restriction endonucleases. Thus, although there is a general pattern of polymorphic restriction enzyme fragments homologous to DQ probes within an HLA-D cluster, the pattern seen for any particular cell line was not sufficiently distinct to assign an HLA-D or DR specificity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987355

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Serological discrimination of DR4 haplotypes by radioimmunoassay.

Authors:  N Tanigaki; R Tosi; G B Ferrara
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  Identification of a polymorphic variant associated with HLA-DQw3 and characterized by specific restriction sites within the DQ beta-chain gene.

Authors:  S J Kim; S L Holbeck; B Nisperos; J A Hansen; H Maeda; G T Nepom
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

3.  Dissection of HLA class II haplotypes in HLA-DR4 homozygous individuals.

Authors:  M G Tilanus; B Morolli; M C van Eggermond; G M Schreuder; R R de Vries; M J Giphart
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

Review 4.  Structural variation among major histocompatibility complex class-II genes which predispose to autoimmunity.

Authors:  G T Nepom
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

5.  Molecular diversity of HLA-DR4 haplotypes.

Authors:  P K Gregersen; M Shen; Q L Song; P Merryman; S Degar; T Seki; J Maccari; D Goldberg; H Murphy; J Schwenzer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

6.  Polymorphisms of DQ beta genes in HLA-DR4 haplotypes from healthy and diabetic individuals.

Authors:  V Henson; N Maclaren; W Riley; E K Wakeland
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  HLA-DQw3.2 allele of the DR4 haplotype is associated with insulin-dependent diabetes; correlation between DQ beta restriction fragments and DQ beta chain variation.

Authors:  D S Monos; R S Spielman; K J Gogolin; S F Radka; L Baker; C M Zmijewski; M Kamoun
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

8.  Exon-specific oligonucleotide probes localize HLA-DQ beta allelic polymorphisms.

Authors:  S L Holbeck; G T Nepom
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

9.  HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters.

Authors:  N Cohen; C Brautbar; M P Font; J Dausset; D Cohen
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

10.  Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis.

Authors:  B S Nepom; J Palmer; S J Kim; J A Hansen; S L Holbeck; G T Nepom
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.